导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -4.69% | 3294/4773 |
| 近一周 | -1.98% | 1003/5462 |
| 近一月 | -2.13% | 1167/5421 |
| 近一季 | -2.04% | 1145/5209 |
| 近半年 | -2.47% | 1908/4920 |
| 近一年 | -1.93% | 2944/4366 |
| 近两年 | 35.12% | 2089/2954 |
| 近三年 | 21.44% | 1420/2253 |
| 成立以来 | 418.13% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.64% 4170/4961 |
6.31% 2839/5312 |
- - |
- - |
| 2025 | 16.35% 2462/4813 |
-0.50% 2276/3635 |
3.00% 1208/4076 |
11.40% 3168/4524 |
1.91% 1161/4813 |
| 2024 | 18.20% 617/3463 |
3.62% 534/2808 |
-0.31% 730/3014 |
17.39% 1199/3129 |
-2.53% 2118/3463 |
| 2023 | -9.24% 1139/2656 |
0.79% 1695/2280 |
-4.80% 1290/2385 |
1.77% 277/2515 |
-7.07% 2038/2655 |
| 2022 | -17.69% 620/2207 |
-11.59% 531/1919 |
6.59% 656/2016 |
-13.73% 963/2113 |
1.25% 1329/2208 |
| 2021 | -9.13% 1072/1822 |
-2.97% 734/1255 |
-0.26% 1135/1330 |
-8.02% 1094/1466 |
2.07% 708/1822 |
| 2020 | 20.65% 712/1250 |
-12.37% 884/1028 |
10.53% 765/1067 |
10.94% 493/1164 |
12.28% 483/1184 |
| 2019 | 35.72% 371/1092 |
23.33% 556/754 |
4.50% 25/804 |
-0.07% 574/850 |
5.38% 725/918 |
| 2018 | -18.36% 143/834 |
- - |
- - |
- - |
-12.32% 434/691 |
| 2017 | 27.17% 92/714 |
- - |
- - |
- - |
- - |
| 2016 | -3.28% 139/605 |
- - |
- - |
- - |
- - |
| 2015 | -4.99% 276/575 |
- - |
- - |
- - |
- - |
| 2014 | 65.93% 20/237 |
- - |
- - |
- - |
- - |
| 2013 | -12.40% 163/186 |
- - |
- - |
- - |
- - |
| 2012 | 17.05% 7/140 |
- - |
- - |
- - |
- - |
| 2011 | -17.24% 14/102 |
- - |
- - |
- - |
- - |
| 2010 | -21.73% 54/58 |
- - |
- - |
- - |
- - |
| 2009 | 83.60% 16/27 |
- - |
- - |
- - |
- - |
| 2008 | -65.26% 25/26 |
- - |
- - |
- - |
- - |
| 2007 | 135.79% 12/22 |
- - |
- - |
- - |
- - |
| 2006 | 127.61% 3/14 |
- - |
- - |
- - |
- - |
| 2005 | -3.25% 7/11 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 华夏上证50ETF VS. 长安沪深300非周期A(740101) |